The GAS5 (growth arrest-specific transcript 5) gene fuses to BCL6 as a result of t(1;3)(q25;q27) in a patient with B-cell lymphoma

Cancer Genetics and Cytogenetics

Volumn 182, Issue 2, 2008, Pages 144-149

  Nakamura, Yuichi ^a   Takahashi, Naoki ^a   Kakegawa, Emi ^a   Yoshida, Katsuhiko ^a   Ito, Yoshihiro ^a   Kayano, Hidekazu ^a   Niitsu, Nozomi ^a   Jinnai, Itsuro ^a   Bessho, Masami ^a  

^a SAITAMA MEDICAL UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH ARREST SPECIFIC PROTEIN 5; OLIGOPYRIMIDINE; PERIPHERAL MYELIN PROTEIN 22; PROTEIN BCL 6; PYRIMIDINE; SMALL NUCLEOLAR RNA; UNCLASSIFIED DRUG;

ADULT; ARTICLE; B CELL LYMPHOMA; BCL6 GENE; CASE REPORT; CHROMOSOME 3Q; CHROMOSOME TRANSLOCATION 1; CHROMOSOME TRANSLOCATION 3; GAS5 GENE; GENE; GENE DISRUPTION; GENE FUSION; HUMAN; IMMUNOGLOBULIN GENE; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL;

BLOTTING, SOUTHERN; CHROMOSOMES, HUMAN, PAIR 1; CHROMOSOMES, HUMAN, PAIR 3; DNA-BINDING PROTEINS; HUMANS; KARYOTYPING; LYMPHOMA, LARGE B-CELL, DIFFUSE; MALE; MIDDLE AGED; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; RNA, SMALL NUCLEOLAR; TRANSLOCATION, GENETIC;

EID: 41749098376     PISSN: 01654608     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cancergencyto.2008.01.013     Document Type: Article

References (29)

1. Ohno H., and Fukuhara S. Significance of rearrangement of the BCL6 gene in B-cell lymphoid neoplasms. Leuk Lymphoma 27 (1997) 53-63
2. Ohno H. Pathogenetic role of BCL6 translocation in B-cell non-Hodgkin's lymphoma. Histol Histopathol 19 (2004) 637-650
3. Ye B.H., Chaganti S., Chang C.C., Niu H., Corradini P., Chaganti R.S.K., and Dalla-Favera R. Chromosomal translocations cause deregulated BCL6 expression by promoter substitution in B cell lymphoma. EMBO J 14 (1995) 6209-6217
4. Chen W., Iida S., Louie D.C., Dalla-Favera R., and Chaganti R.S.K. Heterologous promoters fused to BCL6 by chromosomal translocations affecting band 3q27 cause its deregulated expression during B-cell differentiation. Blood 91 (1998) 603-607
5. Ueda C., Akasaka T., and Ohno H. Non-immunoglobulin/BCL6 gene fusion in diffuse large B-cell lymphoma: prognostic implications. Leuk Lymphoma 43 (2002) 1375-1381
6. Ohno H. Pathogenetic and clinical implications of non-immunoglobulin;BCL6 translocations in B-cell non-Hodgkin's lymphoma. J Clin Exp Hematopathol 46 (2006) 43-53
7. Dalley E., Galiègue-Zouitina S., Collyn-d'Hooghe M., Quief S., Denis C., Hildebrand M.P., Lantoine D., Deweindt C., Tilly H., Bastard C., and Kerckaert J.P. TTF, a gene encoding a novel small G protein, fuses to the lymphoma-associated LAZ3 gene by t(3;4) chromosome translocation. Oncogene 10 (1995) 2171-2178
8. Galiègue-Zouitina S., Quief S., Hildebrand M.P., Denis C., Lecocq G., Collyn-d'Hooghe M., Bastard C., Yuille M., Dyer M.J.S., and Kerckaert J.P. The B cell transcriptional coactivator BOB1/OBF1 gene fuses to the LAZ3/BCL6 gene by t(3;11)(q27;q23.1) chromosome translocation in a B cell leukemia line (Karpas 231). Leukemia 10 (1996) 579-587
9. Akasaka T., Miura I., Takahashi N., Akasaka H., Yonetani N., Ohno H., Fukuhara S., and Okuma M. A recurring translocation, t(3;6)(q27;p21), non-Hodgkin's lymphoma results in replacement of the 5′ regulatory region of BCL6 with a novel H4 histone gene. Cancer Res 57 (1997) 7-12
10. Galiègue-Zouitina S., Quief S., Hildebrand M.P., Denis C., Detourmignies L., Laï J.L., and Kerckaert J.P. Nonrandom fusion of L-Plastin(LCP1) and LAZ3(BCL6) genes by t(3;13)(q27;q14) chromosome translocation in two cases of B-cell non-Hodgkin lymphoma. Genes Chromosomes Cancer 26 (1999) 97-105
11. Yoshida S., Kaneita Y., Aoki Y., Seto M., Mori S., and Moriyama M. Identification of heterologous translocation partner genes fused to the BCL6 gene in diffuse large B-cell lymphomas: 5′-RACE and LA-PCR analyses of biopsy samples. Oncogene 18 (1999) 7994-7999
12. Xu W.S., Liang R.H.S., and Srivastava G. Identification and characterization of BCL6 translocation partner genes in primary gastric high-grade B-cell lymphoma: heat shock protein 89 alpha is a novel fusion partner gene of BCL6. Genes Chromosomes Cancer 27 (2000) 69-75
13. Akasaka H., Akasaka T., Kurata M., Ueda C., Shimizu A., Uchiyama T., and Ohno H. Molecular anatomy of BCL6 translocations revealed by long-distance polymerase chain reaction-based assays. Cancer Res 60 (2000) 2335-2341
14. Hosokawa Y., Maeda Y., Ichinohasama R., Miura I., Taniwaki M., and Seto M. The Ikaros gene, a central regulator of lymphoid differentiation, fuses to the BCL6 gene as a result of t(3;7)(q27;p12) translocation in a patient with diffuse large B-cell lymphoma. Blood 95 (2000) 2719-2721
15. Tanaka R., Satoh H., Moriyama M., Satoh K., Morishita Y., Yoshida S., Watanabe T., Nakamura Y., and Mori S. Intronic U50 small-nucleolar-RNA (snoRNA) host gene of no protein-coding potential is mapped at the chromosome breakpoint t(3;6)(q27;q15) of human B-cell lymphoma. Genes Cells 5 (2000) 277-287
16. Chen W., Itoyama T., and Chaganti R.S.K. Splicing factor SRP20 is a novel partner of BCL6 in a t(3;6)(q27;p21) translocation in transformed follicular lymphoma. Genes Chromosomes Cancer 32 (2001) 281-284
17. Ueda C., Akasaka T., Kurata M., Maesako Y., Nishikori M., Ichinohasama R., Imada K., Uchiyama T., and Ohno H. The gene for interleukin-21 receptor is the partner of BCL6 in t(3;16)(q27;p11), which is recurrently observed in diffuse large B-cell lymphoma. Oncogene 21 (2002) 368-376
18. Akasaka T., Lossos I.S., and Levy R. BCL6 gene translocation in follicular lymphoma: a harbinger of eventual transformation to diffuse aggressive lymphoma. Blood 102 (2003) 1443-1448
19. Montesinos-Rongen M., Akasaka T., Zühlke-Jenisch R., Schaller C., Van Roost D., Wiestler O.D., Siebert R., and Deckert M. Molecular characterization of BCL6 breakpoints in primary diffuse large B-cell lymphomas of the central nervous system identifies GAPD as novel translocation partner. Brain Pathol 13 (2003) 534-538
20. Chen Y.W., Hu X.T., Liang A.C., Au W.Y., So C.C., Wong M.L., Shen L., Tao Q., Chu K.M., Kwong Y.L., Liang R.H., and Srivastava G. High BCL6 expression predicts better prognosis, independent of BCL6 translocation status, translocation partner, or BCL6-deregulating mutations, in gastric lymphoma. Blood 108 (2006) 2373-2383
21. Smith C.M., and Steitz J.A. Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5′-terminal oligopyrimidine gene family reveals common features of snoRNA host genes. Mol Cell Biol 18 (1998) 6897-6909
22. ISCN 1995: an international system for human cytogenetic nomenclature (1995). In: Mitelman F. (Ed) (1995), S. Karger, Basel
23. Chenevix-Trench G., Brown J.A., Tyler G.B., Behm F.G., and Yamabe H. Chromosome analysis of 30 cases of non-Hodgkin's lymphoma. Med Oncol Tumor Pharmacother 5 (1988) 17-32
24. Mitelman F, Johansson B, Mertens F, editors. Mitelman database of chromosome aberrations in cancer [Internet]. Updated August 17, 2007. Accessed on November 19. Available at: http://cgap.nci.nih.gov/Chromosomes/Mitelman.
25. Akasaka T., Ueda C., Kurata M., Akasaka H., Yamabe H., Uchiyama T., and Ohno H. Nonimmunoglobulin (non-Ig)/BCL6 gene fusion in diffuse large B-cell lymphoma results in worse prognosis than Ig/BCL6. Blood 96 (2000) 2907-2909
26. Schneider C., King R.M., and Philipson L. Genes specifically expressed at growth arrest of mammalian cells. Cell 54 (1998) 787-793
27. Maquat L. When cells stop making sense: effects of nonsense codons on RNA metabolism in vertebrate cells. RNA 1 (1995) 453-465
28. Hirose T., Ideue T., Nagai M., Hagiwara M., Shu M.-D., and Steitz J. A spliceosomal intron binding protein, IBP160, links position-dependent assembly of intron-encoded box C/D snoRNP to pre-mRNA splicing. Mol Cell 23 (2006) 673-684
29. Elliott B., Richardson C., and Jasin M. Chromosomal translocation mechanisms at intronic Alu elements in mammalian cells. Mol Cell 17 (2005) 885-894